Retinal ON-pathway dysfunction is implicated in human complete-type congenital stationary night blindness (CSNB1), a Mendelian genetic condition that results from mutations in the NYX gene encoding the protein nyctalopin. We probed cone pathway dysfunction in four human genotyped CSNB1 affected males by electroretinogram (ERG) recordings elicited with photopic sinusoidal and rapid-on/-off ramp flicker stimuli that are Likewise, rapid-on/-off ramping stimuli also indicated that the functional deficit was localized to the ON-pathway. Analysis of non-human primate retinal responses after drug application demonstrated a complexity to ON-/OFF-pathway contributions to ramping on-/off-ERG responses not previously anticipated. These results support the hypothesis that nyctalopin acts principally or exclusively within the ON-pathway at the Retinal ON-pathway dysfunction in human CSNB1-NYX
INTRODUCTION
Human congenital stationary night blindness (CSNB) presents an opportunity to study a retinal visual sensory signaling deficit and model this in non-human monkey primate by retinal application of glutamate analogs. CSNB is a retinal dystrophy characterized by night blindness from birth, presumably due to a retinal pathway signaling defect (Carr 1974) . The condition is considered "stationary" because visual function deteriorates minimally with age, unlike the progressive vision loss leading to blindness in retinitis pigmentosa from degeneration and death of the photoreceptor cells (Berson 1993) . Two genetic forms of X-linked recessive CSNB have been identified which differ clinically in the extent of impairment of dark-adapted sensitivity of the rod system. The "incomplete-type" CSNB2, at Xp11.23 (Bergen et al. 1996; Strom et al. 1998; Rozzo et al. 1999) , from mutations in the gene encoding the alpha-subunit of an Ltype calcium channel, retains partial rod-mediated sensitivity. "Complete-type" CSNB1, at Xp11.4 (Boycott et al. 1998; Rozzo et al. 1999) , results from mutations in the NYX (nyctalopin) gene that encode a novel protein, nyctalopin (Bech-Hansen et al. 2000; Pusch et al. 2000) .
We evaluated retinal function of CSNB1-NYX human subjects. CSNB1 lacks rodmediated visual perception in darkness, and absolute threshold sensitivity is mediated by cones. Although the function of nyctalopin remains unknown, electrophysiology studies of CSNB1 using non-invasive electroretinogram (ERG) recordings indicate that the defect lies post-synaptic to the rod photoreceptors, as the rod-driven a-wave remains normal but the dark-adapted ERG b-wave is absent (Miyake et al. 1986 ). The a-wave originates from hyperpolarization of the rod photoreceptors upon exposure to light stimuli (Granit 1947; Penn and Hagins 1972; Baylor et al. 1984) , whereas the b-wave reflects activity of Retinal ON-pathway dysfunction in human CSNB1-NYX JN-00365-2004.R1 5 post-synaptic bipolar cells directly or indirectly (Gurevich and Slaughter 1993; Xu and Karwoski 1994; Robson and Frishman 1995) . The rod pathology has only depolarizing bipolar cells (DBC) (Dacheux and Raviola 1986; Wassle and Boycott 1991) .
Signaling through the cone pathways is also defective in CSNB1, as the lightadapted ERG b-wave is abnormal in CSNB under photopic conditions with brief photostrobe stimuli (Hill et al. 1974; Heckenlively et al. 1983; Miyake et al. 1986; Young 1991; Quigley et al. 1996) . Localizing this deficit on a cellular/pathway basis is difficult, however, as the cone retinal circuitry involves parallel signaling through DBCs of the cone ON-pathway as well as through hyperpolarizing bipolar cells (HBCs) of the cone OFF-pathway (Sterling et al. 1992) . Although activity of cone-driven DBCs is requisite for generation of the photopic b-wave, cone HBC activity modulates and shapes the response (Sieving et al. 1994 ), making it difficult to parcel out the extent of ON-/OFFpathway involvement in CSNB1 with photostrobe flashes.
Cloning the NYX gene has not resolved this issue, and the cellular mechanism by which nyctalopin causes human night blindness remains uncertain. Nyctalopin encodes a small proteoglycan (Bech-Hansen et al. 2000; Pusch et al. 2000) with 11 leucine-rich repeats (LRRs) that are important for protein-protein interactions (Hocking et al. 1998 ).
Human and mouse nyctalopin are membrane-bound extracellular proteins that localize over the cell surface (Zeitz et al. 2003) . Other LRR family members are involved in cell adhesion and axon guidance (Pusch et al. 2000) . In situ hybridization with a 668-bp NYX antisense probe showed labeling throughout several retinal layers and hence did not localize the functional defect (Bech-Hansen et al. 2000) . Nyctalopin is abundant in the retinal ganglion cell and amacrine cell layers of mouse and rat (Pesch et al. 2003) , but neither ganglion cell nor amacrine cell dysfunction would cause the ERG b-wave
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In this study we used noninvasive ERG recordings to evaluate NYX genotyped CSNB1 males and then correlated this with ERGs recorded identically from non-human monkey primates during intravitreal application of glutamate analogs that suppress lightevoked signaling of depolarizing or hyperpolarizing bipolar cells selectively. Photopic ERG responses were elicited with sinusoidal and ramping rapid-on/-off flicker stimuli that are proposed to probe the cone ON-and OFF-pathways in semi-selective fashion (Kremers et al. 1993; Roveri et al. 1997; Alexander et al. 2001b) , although this latter assertion has not actually been put to robust analysis for ERG studies in either human or monkey. The results localized the CSNB1-NYX photopic functional deficits to the DBC pathway, with no apparent involvement of HBCs. The data also gave insight into the limits of using ramping-on/-off ERG stimuli to probe retinal ON-versus OFF-pathways.
METHODS

Human Subjects
Informed consent was obtained from all subjects under protocols approved by the University of Michigan Medical School Institutional Review Board. Four male subjects, 17 to 20 years old, were studied from three CSNB1 pedigrees. Six clinically normal male and female volunteers, ages 33 to 46 years, were control subjects. Best corrected visual acuity of the CSNB1 subjects was 20/30 to 20/60, except for the right eye of one subject with 20/200 acuity due to amblyopia. Control subjects had 20/20 corrected acuity.
CSNB1 subjects frequently are myopic (Hill et al. 1974; Heckenlively et al. 1983; Quigley et al. 1996; Jacobi et al. 2002; Allen et al. 2003) , and their refractive error range was -6.5
Retinal ON-pathway dysfunction in human CSNB1-NYX JN-00365-2004.R1 7 to -14.00 diopters (D). The controls ranged from -3.5 to -13.00 D. Color vision was normal by Ishihara plate testing for all subjects. Visual fields were full or minimally altered for all subjects with the Goldmann perimetry V4e and I4e targets. Dark-adapted final thresholds were determined after 45 min in the dark with a Goldmann-Weekers Dark-Adaptometer. All four CSNB1 subjects had 2 ½ -3 log elevation of threshold and complete loss of rod-mediated sensitivity. Control subjects had normal thresholds.
Fundus appearance of the CSNB1 subjects was myopic but otherwise unremarkable except for slight pigmentary granularity of the retinal pigment epithelium as can be found in some CSNB individuals (Sieving 1993) .
Genotyping and mutation analysis
DNA was isolated from peripheral blood lymphocytes, and the three NYX exons (Bech-Hansen et al. 2000; Pusch et al. 2000) and flanking intron-exon sequences were amplified using PCR primers (Table 1) 
Human ERG Recording
Pupils were dilated fully with 1% tropicamide and 10% phenylephrine HCl, and 1%
proparacaine corneal topical eye drops were administered for anesthesia prior to placing ERG recording electrodes (bipolar "Gold lens electrodes;" Doran Instruments, Littleton, MA). A neutral recording skin electrode was taped to the forehead. CSNB1
clinical ERG diagnostics were performed according to ISCEV standards (Marmor and
Zrenner 1998) using a Ganzfeld full-field configuration for the brief xenon flash stimulus.
Scotopic recordings were performed first, after an initial 45 min dark-adaptation period, Photopic ERG responses were also elicited with sinusoidal and ramping rapid-on/-off flicker stimuli. "Rapid-on" signifies an abrupt increase in stimulus luminance followed by a ramping decline back to baseline. These stimuli were generated by modulating a densely packed array of 91 red LEDs (623 nm wavelength, 8nm half-width). The 65 mm diameter LED array was placed at the top of an 8 inch diameter integrating bowl with a small viewing port 90 degrees away on the side that was positioned directly in front of the eye to provide a full-field Ganzfeld stimulus. The LED light intensity was controlled by
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Responses were amplified at 10,000 gains from 1-1000 Hz and digitized at 3072 Hz rate.
Amplitude and phase of the fundamental component and higher harmonics of responses to sinusoidal stimuli were derived by Fourier transform analysis (MatLab Signal Processing Toolbox, The MathWorks, Natick, MA).
Monkey ERG recordings and intravitreal drug application
Rhesus monkeys (Macaca mulata) were studied under protocols approved by the Unit of Laboratory Animal Medicine at the University of Michigan. The animals were sedated with ketamine hydrochloride (7 mg/kg IM; 5 to 10 mg/kg/h IM maintenance dose) and xylazine (0.6 mg/kg IM). Supplemental oxygen was given by external nasal cannula.
Respiration and heart rate were monitored. Hydration was maintained by subcutaneous lactated Ringer solution. Pupils were dilated with topical 1% atropine and 2.5% Monitoring of ERG waveforms indicated full drug effects within 1 hour after injection.
Five monkeys not previously studied were employed for ERG recordings, and the sinusoidal flicker results were augmented by data from three monkeys that we partially described previously (Kondo and Sieving 2001). The rapid-on/-off flicker data were generated from the five newly studied monkeys. The effects of APB followed by PDA were determined in two monkeys, and the effects of PDA followed by APB were recorded in three monkeys.
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RESULTS
NYX Gene Mutation Analysis
NYX sequence alterations were found for all four CSNB1 male subjects. Family-A: two affected brothers, subjects S1 and S2, had a novel G to C transversion in exon-3 (803G→C) causing a missense codon change R268P within the leucine rich repeat LRR-9 motif. Secondary structure changes are predicted to alter the turns and coils in the region and local amphipathicity. Family-B: subject S3 had a double nucleotide change (710T→A and 711C→A) in exon 3 causing a missense L237Q in the LRR-8 motif.
These mutations are previously unreported. Family-C: subject S4 had a 24 nucleotide deletion (85-108 del 24 nt) in exon-3 near the protein N-terminus causing an in-frame deletion of eight amino acid residues (29-36) of the N-terminal cysteine cluster. The same 24 bp deletion has been reported previously for seven other apparently independent US families (Bech-Hansen et al. 2000) .
ERG responses to pulse stimuli
None of the four subjects showed rod-mediated threshold sensitivity on clinical examination. Their dark-adapted ERG responses retained normal a-wave amplitudes but essentially lacked the b-wave which was reduced to only about 6% of normal mean 
Sinusoidal flicker ERG recordings
ERG responses to sinusoidal stimuli of CSNB1-NYX subjects were different than controls across a range of stimulus frequencies (Fig. 2) . The CSNB1-NYX waveforms were more sinusoidal than controls across stimulus frequencies of 4-56 Hz, and resembled the monkey waveforms after either PDA (Fig. 3) or APB (e.g. 
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Monkey responses after PDA (Fig. 3) were larger than controls, suggesting that an OFFpathway ERG component normally is antagonistic to the ON-response activity. We previously found larger amplitudes after APB also (Kondo and Sieving 2001) . Applying APB and PDA together to block inner retinal activity showed that the photoreceptor component amplitude declined as stimulus frequency increased (Fig. 3) . human controls, whereas the absolute phase after PDA was quite different from CSNB1-
NYX.
The similarities between CSNB1-NYX and monkey after APB extended to the second harmonic (data not shown). In human and monkey control, the second harmonic had a large contribution near 12 Hz (Burns et al. 1992; Odom et al. 1992) , and its amplitude was comparable to the fundamental amplitude. After APB or PDA, the amplitude of the fundamental component increased (Fig. 4) but the amplitude of the second harmonic increased only slightly at some frequencies. The post-drug behavior of the second harmonic roughly mimicked in CSNB1-NYX, but further studies and detailed analyses will be required to fully determine the effects.
Flicker ERG to rapid-on/-off stimuli
Control Responses:
The ERG was further evaluated using photopic rapid-on and rapid-off ramping stimuli (Fig. 5) . In single unit recordings of monkey retinal ganglion cell activity, these stimuli preferentially stimulate ON-and OFF-pathway activity respectively (Kremers et al. 1993 ). Rapid-on/-off ramp stimuli have been used clinically to probe the relative ONversus OFF-pathway deficits in X-linked retinoschisis by ERG recordings (Alexander et Retinal ON-pathway dysfunction in human CSNB1-NYX JN-00365-2004.R1 18 al. 2001b), in melanoma-associated retinopathy (Alexander et al. 2002) , in carriers of Xlinked retinitis pigmentosa (Alexander et al. 2003) and in human psychophysical studies to investigate the sensitivity to increments and decrements of light (Bowen et al. 1989; Purkiss et al. 2001) . Rapid-on stimuli spaced at longer intervals of 4-24 Hz in normal control subjects elicited the characteristic negative a-and positive b-wave configuration, whereas CSNB1-NYX subjects had only the negative-going a-wave but lacked a discrete b-wave. For stimuli of 32 Hz and above, the intervals were sufficiently short that the components merged for both normals and CSNB1-NYX, and discrete components were difficult to judge. By comparison, with rapid-off stimuli the CSNB1-NYX subjects had responses quite similar to normals although slightly larger; the positive response to rapid-off stimuli corresponded to the d-wave observed at termination of a step stimulus (Fig. 1) .
Monkey responses to rapid-on and rapid-off ramp stimuli were dissected into constituent pathway components by drug application (Fig 6) . Responses after either APB or PDA alone were larger than control for at least some stimulus frequencies, indicating that both pathways contribute to control responses, as would readily be suspected from the waveform alone at 4 Hz. However, a finding that is surprising in view of the previous literature is the origin of responses evoked by rapid-off ramping stimuli. The positive-going response after APB is considerably larger than the control, implying that ON-pathway activity normally contributes to the control response for rapid-off stimuli. The ON-pathway contribution can be appreciated by the residual waveform after applying only PDA, which leaves the ONpathway plus cone photoreceptor activity. Again, substantial ON-pathway activity is found beyond that attributed to cones activity directly (i.e. the waveform after giving both APB and PDA). Consequently, rapid-off ramping stimuli do not selectively isolate OFFpathway activity, although this strategy has been employed in literature (e.g. Alexander et
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Drug sensitive components to rapid-on/-off stimuli:
ON-and OFF-pathway activity was isolated by waveform subtractions after drug application in monkey (Gurevich and Slaughter 1993; Sieving et al. 1994; Robson and Frishman 1995; Hood et al. 2002) and then compared with the CSNB1 subjects. The APB-sensitive component in Fig 
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In each case, the leading edge of the isolated components was the most robust to pharmacologic isolation. The cause of the waveform deviation that trails the response peak of isolated components is not known, but it may represent some interaction of ON-/OFF-pathways through an anatomical circuit or through extracellular potassium (Sieving et al. 1994) . We recorded these responses across a range of stimulus frequencies, but
Comparison of CSNB1 and monkey responses
Finally, we compared responses of a representative human CSNB1-NYX to drugisolated monkey components (Fig. 8) . 
DISCUSSION
The ERG of human subjects with genetic CSNB1-NYX retinal dystrophy showed considerable congruence with a non-human experimental model of retinal ON-pathway deficit created pharmacologically in monkey using APB. CSNB1 human responses were replicated in monkey when APB was applied alone and with the OFF-pathway remaining active. There was no indication of involvement of the HBC OFF-pathway. The results support the proposition that nyctalopin plays a major role within the ON-pathway at the level of DBCs or their input from cones. JN-00365-2004.R1 26 None of the four CSNB1 males showed the response amplitude dip near 12 Hz which normal controls exhibited to sinusoidal stimuli (Burns et al. 1992; Odom et al. 1992; Alexander et al. 2000) . amplitude decreased monotonically for stimulus frequencies above 4 or 8 Hz, for sinusoidal as well as for rapid-on/-off ramping stimuli. Although Burns et al (1992) attributed the fall-off of high frequency response to an early temporal filter within the cone photoreceptors, the present data and our past results with flicker ERG in monkey indicate that the cones directly contribute very little above 16 Hz. Hence it is unlikely that much of the CSNB1-NYX amplitude reduction at higher frequencies results from a lack of photoreceptor amplitude. It is possible however, that APB and PDA may also have effects elsewhere in the retina including horizontal cell feedback onto photoreceptors in some species (Nawy 1989; Yang 1989; Massey 1995) . Blocking horizontal cell feedback could reduce photoreceptor flicker amplitude in vivo.
NYX mutations in these three families.
All four CSNB1-NYX males had similar ERG responses despite three different mutations in the NYX gene. The mutations in all three families involved the leucine rich repeat LRR regions of the protein, in structurally conserved residues of the gene product that are predicted to coincide with a considerable neuro-signaling deficit (Jacobi et al. 2002) . All four CSNB1-NYX affected males had high myopia (-6.5 to -14.00 D) and had subnormal ERG b/a-ratios of 0.45 to 0.88 (normally greater than 1.0), similar to findings of 12 CSNB1 males with NYX mutations in conserved domains (Jacobi et al. 2002) . A majority of the missense mutations reported previously also localized to LRR regions:
LRRs NT, 4, 5, 6, 11, CT (Pusch et al. 2000) and LRRs NT, 4, 6, 8, 9, 10 (Bech-Hansen et al. 2000) , indicating a critical role of these motifs in nyctalopin function.
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Possible residual rod pathway function in some CSNB1
While our CSNB1-NYX subjects did not appear to have residual rod pathway function, evidence from other studies suggests that, although greatly impaired, some residual rod system function may remain for some CSNB1-NYX males (Bech-Hansen et al. 2000; Scholl et al. 2001; Allen et al. 2003) , possibly through an alternate rod pathway.
Mammalian rods contact a single type of bipolar cell (Dowling and Boycott 1966;
Dacheux and Raviola 1986; Boycott and Wassle 1991), but a second pathway for rod signals has been suggested through gap junctions onto cones and then to the cone bipolar cells (Nelson, 1977; Smith, 1986; DeVries, 1995; Schneeweis and Schnaff, 1995) . sinusoidal and ramping rapid-on/-off stimuli were similar in controls and CSNB1-NYX, as well as after APB in monkey. One could speculate that nyctalopin acts mostly on the b2 and b3 bipolar cells and less on the b1 cell.
Central vision in CSNB1-NYX
CSNB1-NYX individuals essentially never reach normal acuity (Krill and Martin 1971; Heckenlively et al. 1983; Miyake et al. 1986; Young et al. 1986; Jacobi et al. 2002) ,
indicating that ON-pathway processing is required to take full visual advantage of spatial sampling by the foveal cone photoreceptor matrix. Though unlikely, one must ask whether foveal cone spacing is altered in CNSB1.
Color vision in CSNB1-NYX is surprisingly good despite the cone ON-pathway dysfunction. Short-wavelength-sensitive cone (S-cone) ERGs are non-recordable to fullfield stimuli in CSNB (Kamiyama et al. 1996) . Recently, blue-on-yellow perimetry in CSNB1 patients, however, showed normal blue cone sensitivity in the central retina, but this became abnormal in the periphery (Terasaki et al. 1999) . Anatomical evidence indicates that primate foveal S cones contact ON blue bipolar cells (Mariani 1984; Kouyama and Marshak 1992; Klug et al. 2003) . Unlike the L or M cones, however, the S cones are not presynaptic to their own depolarizing midget bipolar cells. Rather, S cones contact hyperpolarizing midget bipolar cells (Kolb et al. 1997; Ahmad et al. 2003; Klug et al. 2003) which provide chromatic input to ganglion cells in both the fovea and periphery (Boycott and Wassle 1991) . Blocking only the ON pathway with APB did not change the shape of the spectral sensitivity function, but it reduced sensitivity uniformly across all wavelengths, suggesting that the OFF pathway can carry short-wavelength information (Smith et al. 1989 ).
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Analysis of the primate photopic b-wave using pharmacological separation of
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Rapid-on/off ramping stimuli have been used in psychophysical (Bowen et al. 1989; Purkiss et al. 2001) and in physiological primate studies (Kremers et al. 1993 ) to separate the two pathways. Some have used these stimuli to explore pathway deficits in several human hereditary retinal dystrophies (Alexander et al. 2001b (Alexander et al. , 2002 (Alexander et al. , 2003 with the expectation that the rapid-on/-off stimulus paradigms are relatively selective for the respective retinal physiological ON-/OFF-pathways. This possibility was not tested experimentally, however, prior to the ERG data presented here. This is the first study of primate ERGs to rapid-on/-off ramping stimuli during pharmacologic separation of ONand OFF-pathway activity. To our disappointment, the data show that these stimuli are non-specific for pathway separation and yield complex ERG responses in primate.
Rapid-on stimuli elicit considerable activity of both the ON-and OFF-pathways, as does the rapid-off stimulus. Neither is truly selective for a single pathway.
The caveat, however, is that pharmacological dissection may not yield unequivocally complete isolation of components. This seems to be less of a concern for APB results than with PDA which can also act on horizontal cells and third-order neurons of some species (Slaughter and Miller 1985) . APB is a highly selective competitive antagonist at the mGluR6 receptor which localizes exclusively at the metabotropic Gprotein coupled synapse between rod and cone photoreceptors and their respective DBCs (Shiells et al. 1981; Slaughter and Miller 1981 Hence, it is important to note the remarkable convergence of results of pharmacologic manipulation in monkey and genetic alteration in these four CSNB1-NYX subjects. CSNB1 individuals apparently afford the opportunity to probe the consequences to visual function of eliminating ON-pathway signaling in the human primate retina.
These ERG findings with rapid-on/-off stimuli extend previous results for brief strobe flicker and 30 Hz sinewave (Bush and Sieving 1996; Kim et al. 1997; Kondo and Sieving 2001, 2002) . In all cases the photopic ERG waveforms showed major postphotoreceptoral contributions. The results presented here with sawtooth modulated flicker stimuli similarily are largely from the inner retina, particularly for stimuli above 16
Hz. Further development of ERG analyses is warranted, to determine the extent to which attribution to a specific pathway might be extracted from such waveforms.
Third-order neuron signaling in CSNB1-NYX
In situ study showed NYX expression across all retinal layers including amacrine cells of the inner nuclear layer (Bech-Hansen et al. 2000) , raising a question of whether ERG abnormalities might be attributed to deficient signaling by third-order neurons.
Retinal amacrine and ganglion cell neurons do not contribute substantially to sinusoidal flicker responses in monkey, and the contributions to the fundamental component are small in comparison to those from bipolar cells (Viswanathan et al. 2002) . Blocking inner retinal activity of ganglion and amacrine cells with TTX and NMDLA shifted the Retinal ON-pathway dysfunction in human CSNB1-NYX JN-00365-2004.R1 34 amplitude dip in the response fundamental to a lower stimulus frequency and the maximum to higher stimulus frequency (Viswanathan et al. 2002) . This is dissimilar to our sinusoidal stimuli results with CSNB1-NYX subjects, in which the amplitude dip was abolished and the maximum remained near 30 Hz. In the least, this reinforces that the cellular locus of dysfunction likely involves a site other than or in addition to third-order neurons.
Several ERG studies of CSNB suggested that signaling is deficient through the proximal retina. Miyake et al (1994) 
Speculations on the functional role of nyctalopin
In situ hybridization with a 668-bp antisense probe corresponding to the NYX 3'
UTR region showed labeling of several retinal layers, including the inner layers and retinal ganglion cells (Bech-Hansen et al. 2000) . Immunohistochemical studies in the nob mouse to examine the distribution of proteins in the outer plexiform layer that have been implicated in DBC function showed no abnormalities in the rod bipolar cell dendrite morphology (Ball et al. 2003) indicating that the absence of nyctalopin does not disrupt the expression pattern of other proteins which are necessary for synaptic transmission.
NYX is also expressed in kidney (Bech-Hansen et al. 2000) and possibly other tissues (Pusch et al. 2000) , although human CSNB1 subjects are not known to have renal or other systemic abnormalities. Nyctalopin expression in the nob mouse carrying a murine NYX mutation was greatest in the inner nuclear layer that contains bipolar, horizontal and amacrine cells (Gregg et al. 2003) . Consequently these studies provide few clues as to specific ON-/OFF-pathway deficits.
NYX in situ analysis suggested that nyctalopin might play a role in neural retinal development (Bech-Hansen et al. 2000) , evidently involving DBCs only and not HBC circuitry from the ERG results presented here. Further suggestions were that nyctalopin might be important for establishing or maintaining functional connections between the rod photoreceptors and the postsynaptic bipolar cells (Pusch et al. 2000) , and again it remains unknown how only DBCs and not HBC synapses are targeted. Hence, it is worthwhile to develop further evidence that human CSNB1 involves only the ONpathway activity. In the context of the present study implicating DBCs and not HBC, it will be useful to learn whether nyctalopin specifically localizes to the soma or the synapse.
